{"id":428063,"date":"2021-02-03T13:28:05","date_gmt":"2021-02-03T18:28:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=428063"},"modified":"2021-02-03T13:28:05","modified_gmt":"2021-02-03T18:28:05","slug":"gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/","title":{"rendered":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH"},"content":{"rendered":"

<\/p>\n

GWPH <\/b>Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of <\/b>GW Pharmaceuticals plc<\/b> Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nHalper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders in connection with the proposed sale of GW Pharmaceuticals to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS).\n<\/p>\n

\nOn behalf of GW Pharmaceuticals shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.\n<\/p>\n

\nHalper Sadeh encourages GW Pharmaceuticals shareholders to click here to learn more about their legal rights and options<\/a><\/b><\/span> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nHalper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.\n<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210203005825\/en\/<\/a><\/span><\/p>\n

\nHalper Sadeh LLP
\n
Daniel Sadeh, Esq.
\n
Zachary Halper, Esq.
\n
(212) 763-0060
\n
sadeh@halpersadeh.com
\n<\/a>
zhalper@halpersadeh.com
\n<\/a>
https:\/\/www.halpersadeh.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders in connection with the proposed sale of GW Pharmaceuticals to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). On behalf of GW Pharmaceuticals shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or … <\/p>\n

Continue reading “GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-428063","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders in connection with the proposed sale of GW Pharmaceuticals to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). On behalf of GW Pharmaceuticals shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or … Continue reading "GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-03T18:28:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH\",\"datePublished\":\"2021-02-03T18:28:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/\",\"name\":\"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-02-03T18:28:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/","og_locale":"en_US","og_type":"article","og_title":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk","og_description":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders in connection with the proposed sale of GW Pharmaceuticals to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). On behalf of GW Pharmaceuticals shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or … Continue reading \"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-03T18:28:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH","datePublished":"2021-02-03T18:28:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/","name":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-02-03T18:28:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210203005825r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gwph-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-gw-pharmaceuticals-plc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-gwph\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 GWPH"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/428063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=428063"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/428063\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=428063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=428063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=428063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}